These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 26086825)

  • 21. Development and validation of a prognostic multivariable model to predict insufficient clinical response to methotrexate in rheumatoid arthritis.
    de Rotte MCFJ; Pluijm SMF; de Jong PHP; Bulatović Ćalasan M; Wulffraat NM; Weel AEAM; Lindemans J; Hazes JMW; de Jonge R
    PLoS One; 2018; 13(12):e0208534. PubMed ID: 30532219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic polymorphisms in low-dose methotrexate transporters: current relevance as methotrexate therapeutic outcome biomarkers.
    Lima A; Sousa H; Monteiro J; Azevedo R; Medeiros R; Seabra V
    Pharmacogenomics; 2014; 15(12):1611-35. PubMed ID: 25340735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis.
    James HM; Gillis D; Hissaria P; Lester S; Somogyi AA; Cleland LG; Proudman SM
    J Rheumatol; 2008 Apr; 35(4):562-71. PubMed ID: 18322994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacogenomics of methrotexate: a strategy for a customized therapeutic scheme for patients with rheumatoid arthritis].
    Mena-Ramírez JP; Salazar-Páramo M; Dávalos-Rodríguez IP
    Gac Med Mex; 2008; 144(5):449-51. PubMed ID: 19043967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidrug resistance protein-1 expression, function and polymorphisms in patients with rheumatoid arthritis not responding to methotrexate.
    Prasad S; Tripathi D; Rai MK; Aggarwal S; Mittal B; Agarwal V
    Int J Rheum Dis; 2014 Nov; 17(8):878-86. PubMed ID: 24734954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors Predicting the Therapeutic Response to Methotrexate in Japanese Patients with Rheumatoid Arthritis: A Hospital-Based Cohort Study.
    Hakamata J; Kaneko Y; Shimizu M; Yamaoka K; Maruyama J; Takeuchi T; Mochizuki M; Hashiguchi M
    Biol Pharm Bull; 2018; 41(9):1414-1422. PubMed ID: 30175777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methotrexate pharmacogenetics in rheumatoid arthritis: a status report.
    Malik F; Ranganathan P
    Pharmacogenomics; 2013 Feb; 14(3):305-14. PubMed ID: 23394392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of a clinical pharmacogenetics model to predict methotrexate response in patients with rheumatoid arthritis.
    López-Rodríguez R; Ferreiro-Iglesias A; Lima A; Bernardes M; Pawlik A; Paradowska-Gorycka A; Świerkot J; Slezak R; Gonzalez-Alvaro I; Narvaez J; Pérez-Pampín E; Mera-Varela A; Vidal-Bralo L; Acuña-Ochoa JG; Conde C; Gonzalez A
    Pharmacogenomics J; 2018 Jul; 18(4):539-545. PubMed ID: 29520081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes.
    Wessels JA; de Vries-Bouwstra JK; Heijmans BT; Slagboom PE; Goekoop-Ruiterman YP; Allaart CF; Kerstens PJ; van Zeben D; Breedveld FC; Dijkmans BA; Huizinga TW; Guchelaar HJ
    Arthritis Rheum; 2006 Apr; 54(4):1087-95. PubMed ID: 16572443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD39 positive regulatory T cell frequency as a biomarker of treatment response to methotrexate in rheumatoid arthritis.
    Gupta V; Katiyar S; Singh A; Misra R; Aggarwal A
    Int J Rheum Dis; 2018 Aug; 21(8):1548-1556. PubMed ID: 30146748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can we predict unresponsiveness to methotrexate in rheumatoid arthritis? A pharmacogenetic study.
    Melikoglu MA; Balkan E
    Inflammopharmacology; 2022 Feb; 30(1):193-197. PubMed ID: 35043269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Membrane-Spanning Protein Genetic Polymorphisms Related to Methotrexate Therapeutic Outcomes in a Chinese Rheumatoid Arthritis Population.
    Lv S; Fan H; Yang H; Huang J; Li J; Shu X; Zhang L; Xu Y; Li X; Zuo J; Lv C; Kong X; Xiao C
    J Clin Pharmacol; 2019 Nov; 59(11):1471-1476. PubMed ID: 31099054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of the ATIC 347 C/G polymorphism with responsiveness to and toxicity of methotrexate in rheumatoid arthritis: a meta-analysis.
    Lee YH; Bae SC
    Rheumatol Int; 2016 Nov; 36(11):1591-1599. PubMed ID: 27379764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methotrexate pharmacokinetic genetic variants are associated with outcome in rheumatoid arthritis patients.
    Moya P; Salazar J; Arranz MJ; Díaz-Torné C; del Río E; Casademont J; Corominas H; Baiget M
    Pharmacogenomics; 2016; 17(1):25-9. PubMed ID: 26652611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic polymorphisms in folate pathway enzymes as a possible marker for predicting the outcome of methotrexate therapy in Japanese patients with rheumatoid arthritis.
    Hayashi H; Fujimaki C; Daimon T; Tsuboi S; Matsuyama T; Itoh K
    J Clin Pharm Ther; 2009 Jun; 34(3):355-61. PubMed ID: 19827168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphisms and pharmacogenomics for the toxicity of methotrexate monotherapy in patients with rheumatoid arthritis: A systematic review and meta-analysis.
    Qiu Q; Huang J; Lin Y; Shu X; Fan H; Tu Z; Zhou Y; Xiao C
    Medicine (Baltimore); 2017 Mar; 96(11):e6337. PubMed ID: 28296761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis.
    Berkun Y; Abou Atta I; Rubinow A; Orbach H; Levartovsky D; Aamar S; Arbel O; Dresner-Pollak R; Friedman G; Ben-Yehuda A
    J Rheumatol; 2007 Aug; 34(8):1664-9. PubMed ID: 17611986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pharmacogenetics of methotrexate.
    Hider SL; Bruce IN; Thomson W
    Rheumatology (Oxford); 2007 Oct; 46(10):1520-4. PubMed ID: 17586865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-wide analysis of methotrexate pharmacogenomics in rheumatoid arthritis shows multiple novel risk variants and leads for TYMS regulation.
    Senapati S; Singh S; Das M; Kumar A; Gupta R; Kumar U; Jain S; Juyal RC; Thelma BK
    Pharmacogenet Genomics; 2014 Apr; 24(4):211-9. PubMed ID: 24583629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methotrexate impact on radiographic progression in biologic-treated rheumatoid arthritis under clinical remission: A case report on monozygotic Caucasian twins.
    Soukup T; Nekvindova J; Dosedel M; Brtkova J; Toms J; Bastecka D; Bradna P; Vlcek J; Pavek P
    Int J Immunopathol Pharmacol; 2016 Dec; 29(4):790-795. PubMed ID: 27770044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.